A reassessment of biochemical marker distributions in trisomy 21-affected and unaffected twin pregnancies in the first trimester

Ultrasound in Obstetrics and Gynecology

Volumn 37, Issue 1, 2011, Pages 38-47

  Madsen, H N ^a   Ball, S ^b   Wright, D ^b   Tarring N ^a   Petersen, O B ^a   Nicolaides, K H ^c   Spencer, K ^d  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF PLYMOUTH   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d KING GEORGE HOSPITAL   (United Kingdom)

Author keywords

chorionicity; first trimester; free hCG; PAPP A; trisomy 21; twins

Indexed keywords

BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; BLOOD; DOWN SYNDROME; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MASS SCREENING; MATERNAL AGE; METABOLISM; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PRENATAL DIAGNOSIS; TWINS; VALIDATION STUDY;

ADULT; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; MASS SCREENING; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; TWINS;

EID: 78650653795     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.8845     Document Type: Article

References (22)

1. Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH,. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2008; 31: 618-624.
2. Kagan KO, Wright D, Valencia C, Maiz N, Nicolaides KH,. Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A. Hum Reprod 2008; 23: 1968-1975.
3. Spencer K, Nicolaides KH,. A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free beta-hCG and PAPP-A. Prenat Diagn 2002; 22: 877-879.
4. Spencer K, Kagan KO, Nicolaides KH,. Screening for trisomy 21 in twin pregnancies in the first trimester: an update of the impact of chorionicity on maternal serum markers. Prenat Diagn 2008; 28: 49-52.
5. Monteagudo A, Timor-Tritsch IE, Sharma S,. Early and simple determination of chorionic and amniotic type in multifetal gestations in the first fourteen weeks by high-frequency transvaginal ultrasonography. Am J Obstet Gynecol 1994; 170: 824-829.
6. Sepulveda W, Sebire NJ, Hughes K, Odibo A, Nicolaides KH,. The lambda sign at 10-14 weeks of gestation as a predictor of chorionicity in twin pregnancies. Ultrasound Obstet Gynecol 1996; 7: 421-423.
7. Sebire NJ, Snijders RJ, Hughes K, Sepulveda W, Nicolaides KH,. Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Br J Obstet Gynaecol 1996; 103: 999-1003.
8. Vandecruys H, Faiola S, Auer M, Sebire N, Nicolaides KH,. Screening for trisomy 21 in monochorionic twins by measurement of fetal nuchal translucency thickness. Ultrasound Obstet Gynecol 2005; 25: 551-553.
9. Spencer K,. Screening for trisomy 21 in twin pregnancies in the first trimester using free beta-hCG and PAPP-A, combined with fetal nuchal translucency thickness. Prenat Diagn 2000; 20: 91-95. (Pubitemid 30103459)
10. Spencer K, Nicolaides KH,. First trimester prenatal diagnosis of trisomy 21 in discordant twins using fetal nuchal translucency thickness and maternal serum free beta-hCG and PAPP-A. Prenat Diagn 2000; 20: 683-684.
11. Spencer K, Nicolaides KH,. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience. BJOG 2003; 110: 276-280. (Pubitemid 36298911)
12. Linskens IH, Spreeuwenberg MD, Blankenstein MA, van Vugt JM,. Early first-trimester free beta-hCG and PAPP-A serum distributions in monochorionic and dichorionic twins. Prenat Diagn 2009; 29: 74-78.
13. Kirkegaard I, Petersen OB, Uldbjerg N, TÃrring N,. Improved performance of first-trimester combined screening for trisomy 21 with the double test taken before a gestational age of 10 weeks. Prenat Diagn 2008; 28: 839-844.
14. TÃrring N,. Performance of first-trimester screening between gestational weeks 7 and 13. Clin Chem 2009; 55: 1564-1567.
15. Loughna P, Chitty L, Evans T, Chudleigh T,. Fetal size and dating: charts recommended for clinical obstetric practice. Ultrasound 2009; 17: 161-167.
16. Robinson HP, Fleming JE,. A critical evaluation of sonar "crown-rump length" measurements. Br J Obstet Gynaecol 1975; 82: 702-710.
17. Wright D, Spencer K, Kagan KO, TÃrring N, Petersen OB, Christou A, Kallikas J, Nicolaides KH,. First trimester combined screening for trisomy 21 at 8-13 weeks. Ultrasound Obstet Gynecol 2010; 36: 404-411.
18. Wright D, Kagan KO, Molina FS, Gazzoni A, Nicolaides KH,. A mixture model of nuchal translucency thickness in screening for chromosomal defects. Ultrasound Obstet Gynecol 2008; 31: 376-383.
19. Cuckle H, Aitken D, Goodburn S, Senior B, Spencer K, Standing S,. Age-standardisation when target setting and auditing performance of Down syndrome screening programmes. Prenat Diagn 2004; 24: 851-856.
20. Woodward M,. Epidemiology: Study Design and Data Analysis. Chapman and Hall: New York, 1999.
21. Cuckle H,. Down's syndrome screening in twins. J Med Screen 1998; 5: 3-4.
22. Wald NJ, Rish S,. Prenatal screening for Down syndrome and neural tube defects in twin pregnancies. Prenat Diagn 2005; 25: 740-745.